Japan halts use of 1.63 mil. Moderna vaccine doses over contamination
Japan's health ministry said Thursday foreign materials were found in some portions of unused doses of Moderna Inc.'s COVID-19 vaccine and the use of around 1.63 million doses manufactured in the same production line has been suspended as a precaution. Japanese drugmaker Takeda Pharmaceutical Co., which is in charge of sales and distribution of the vaccine in the country, said it has yet to see any reports of safety issues. Some of the 1.63 million doses distributed to 863 vaccination centers have already been used. The size of foreign substances confirmed in 39 vials is believed to be a few millimeters, with their elements being unknown. Moderna is conducting an investigation into the materials, according to the ministry and Takeda. The Ministry of Health, Labor and Welfare said foreign substances have been confirmed since Aug. 16 at eight vaccination sites in the prefectures of Ibaraki, Saitama, Tokyo, Gifu and Aichi. Takeda reported them to the ministry on Wednesday.
- Product Code
- ILEA000689577
- Registered date
- 2021/8/26 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media size
- 1920 × 1080 pixel
- Deployment size
- 200.55(MB)*
*File size when opened in Photoshop, etc.